Bandingkan Harga & Kinerja Indofarma Tbk. (INAF) vs Maskapai Reasuransi Indonesia Tbk. (MREI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Indofarma Tbk. dan Maskapai Reasuransi Indonesia Tbk.: Indofarma Tbk. diperdagangkan di Rp126 (kapitalisasi pasar 390,51 M), sedangkan Maskapai Reasuransi Indonesia Tbk. diperdagangkan di Rp920 (kapitalisasi pasar 476,37 M). Perbedaan utamanya: Maskapai Reasuransi Indonesia Tbk. lebih besar dari sisi kapitalisasi pasar. Mana yang lebih baik tergantung tujuan investasimu.
| INAF | MREI | |
|---|---|---|
Kapitalisasi Pasar | 390,51 M | 476,37 M |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Indofarma Tbk.
PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.
Selengkapnya di halaman INAF →Tentang Maskapai Reasuransi Indonesia Tbk.
PT Maskapai Reasuransi Indonesia Tbk (the Company) was established on 4th June 1953 based on Notarial Deed No. 15 of Anton Frederik Schut a substitute of Meester Karel Esuard Krijgsman, notary in Jakarta.In 1998 PT. Dharmala Sakti Sejahtera became one of Marein’s major shareholders, besides AJB Bumiputera 1912, and as the result the company was able to increase its paid up capital to Rp 3,002,500,000.
Selengkapnya di halaman MREI →
